Feed HNSBF
HN
Hansa Biopharma AB
HNSBF · OTC
$2.90 +0.00% (+$0.00)
1M +0.00%
Market Cap $245.8M
P/E Ratio -
Div. Yield -
ROE 118.61%
Bulios Fair Price
$178.55
6056.9% upside
Aktuální cena
$2.9
Podhodnoceno Férová hodnota Nadhodnoceno
Valuation
62 /100
Fair P/S 1.63x
EV/FFO N/A
P/B N/A
Growth
71 /100
Growing Rev. growth 12.88%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 0.00%
Op. margin 0.00%
FCF margin 0.00%
Quality
45 /100
Average ROE 118.61%
ROA 0.00%
Asset turnover 1.92x
Debt
51 /100
Moderate Int. coverage -2.41x
Net debt/EBITDA -0.20x
Current ratio 1.11x
Stability
24 /100
Unstable Rev. volatility 24.25%
EPS volatility 32.73%
Profitable years 0
Zeptejte se StockBota na HNSBF
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Renée Julie Elisabet Aguiar-Lucander
Employees
125
Headquarters
Lund